JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Support: [email protected]

Track Your Order

HDAC

A4106 Scriptaid
1 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor,novel and cell-permeable

insoluble in H2O; ≥13.1 mg/mL
A4105 M344
1 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor,potent and cell-permeable
A4104 AR-42 (OSU-HDAC42)
2 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor,novel and potent

insoluble in EtOH; insoluble in H2O; ≥15.62 mg/mL
A4103 LAQ824 (NVP-LAQ824,Dacinostat)
1 Citation

Summary: HDAC inhibitor,potent and novel

insoluble in H2O; insoluble in EtOH; ≥17.45 mg/mL
A4102 CI994 (Tacedinaline)
1 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor

insoluble in H2O; insoluble in EtOH; ≥50 mg/mL
A4101 Tubastatin A
6 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC6 inhibitor,potent and selective

insoluble in EtOH; insoluble in H2O; ≥10.75 mg/mL
A4100 Droxinostat
2 Citation

Summary: Selective HDAC inhibitor
A4098 PCI-24781 (CRA-024781)

Target: Histone Deacetylases (HDACs)

Summary: Pan-HDAC inhibitor

insoluble in H2O; insoluble in EtOH; ≥11.75 mg/mL
A4097 CUDC-907

Target: Histone Deacetylases (HDACs)|PI3K

Summary: Potent PI3K/HDAC inhibitor

≥25.45 mg/mL
A4096 Belinostat (PXD101)
2 Citation

Target: Histone Deacetylases (HDACs)

Summary: Hydroxamate-type HDAC inhibitor

insoluble in H2O; ≥15.92 mg/mL